Offer - Urjas Oil for just ₹ 1 X
Respik Plus is a prescription drug, available for use as Tablet. It is typically used for the treatment of Schizophrenia. Respik Plus also has some secondary and off-label uses. These are listed below.
The optimal dosage of Respik Plus is largely dependent on the individual's body weight, medical history, gender and age. Individual symptoms and route of administration also determines the right dosage. This information has been provided in detail in the dosage section.
Apart from the aforementioned side effects, Respik Plus can also lead to other problems, which have been listed below. Usually, these side effects of Respik Plus go away soon, and do not persist beyond the duration of the treatment. Please speak with your doctor if these side effects worsen or persist for a longer duration.
It is also important to note that Respik Plus has a Moderate effect for pregnant women and Severe effect on lactating mothers. In addition, Respik Plus's effects on the liver, heart and kidney are discussed below in the Respik Plus related warnings section.
Respik Plus can cause adverse effects in certain medical conditions. It is strongly recommended to avoid Respik Plus in conditions like Tardive Dyskinesia, Kidney Disease, Liver Disease. Other contraindications of Respik Plus have been discussed in the sections ahead.
Drug interactions for Respik Plus have been reported in the medical literature. See below for a complete list.
In addition to these precautions, you may also note that Respik Plus is not safe while driving, and is is not addictive in nature.
Respik Plus is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Adult |
|
Geriatric |
|
13 - 18 years (Adolescent) |
|
2 - 12 years (Child) |
|
Is the use of Respik Plus safe for pregnant women?
Respik Plus may cause moderate side effects during pregnancy. If you feel its harmful effects, then stop taking this drug immediately, and do not take Respik Plus again without your doctor's advice.
Is the use of Respik Plus safe during breastfeeding?
Women who are breastfeeding, may experience serious side effects after taking Respik Plus. So it is adviced to consult the doctor before using it.
What is the effect of Respik Plus on the Kidneys?
Respik Plus rarely harms the kidneys.
What is the effect of Respik Plus on the Liver?
Side effects of Respik Plus rarely affect the liver.
What is the effect of Respik Plus on the Heart?
Respik Plus is rarely harmful for the heart.
Respik Plus should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
If you are suffering from any of the following diseases, you should not take Respik Plus unless your doctor advises you to do so -
Is this Respik Plus habit forming or addictive?
Respik Plus is not addictive in nature.
Is it safe to drive or operate heavy machinery when consuming?
After taking Respik Plus, you should not drive or work on any heavy machine, as Respik Plus can make you drowsy.
Is it safe?
Respik Plus is safe but it is important to consult a doctor before taking it.
Is it able to treat mental disorders?
Yes, Respik Plus is useful in treating mental disorders.
Interaction between Food and Respik Plus
Eating certain foods may increase the time it takes Respik Plus to have an effect. You should consult your doctor about it.
Interaction between Alcohol and Respik Plus
Taking Respik Plus with alcohol can have severely harmful effects on your health.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Risperdal® (risperidone)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 441-442
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 1101-1103